Catalyst Pharmaceuticals (CPRX) EPS (Weighted Average and Diluted): 2018-2025
Historic EPS (Weighted Average and Diluted) for Catalyst Pharmaceuticals (CPRX) over the last 8 years, with Sep 2025 value amounting to $0.42.
- Catalyst Pharmaceuticals' EPS (Weighted Average and Diluted) rose 20.00% to $0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.72, marking a year-over-year increase of 45.76%. This contributed to the annual value of $1.31 for FY2024, which is 107.94% up from last year.
- According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' EPS (Weighted Average and Diluted) is $0.42, which was up 2.44% from $0.41 recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.45 during Q1 2025, and its lowest value of -$0.29 during Q3 2023.
- In the last 3 years, Catalyst Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of $0.33 in 2024 and averaged $0.29.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 245.00% in 2023, then soared by 220.69% in 2024.
- Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.09 in 2021, then spiked by 155.56% to $0.23 in 2022, then skyrocketed by 34.78% to $0.31 in 2023, then spiked by 41.94% to $0.44 in 2024, then increased by 20.00% to $0.42 in 2025.
- Its last three reported values are $0.42 in Q3 2025, $0.41 for Q2 2025, and $0.45 during Q1 2025.